Vis enkel innførsel

dc.contributor.authorNiemeijer, Andre
dc.contributor.authorLund, Hans
dc.contributor.authorStafne, Signe Nilssen
dc.contributor.authorIpsen, Thomas
dc.contributor.authorGoldschmidt, Cathrine Luhaäär
dc.contributor.authorJørgensen, Claus Thomas
dc.contributor.authorJuhl, Carsten B.
dc.date.accessioned2020-03-13T12:05:38Z
dc.date.available2020-03-13T12:05:38Z
dc.date.created2019-10-22T12:38:23Z
dc.date.issued2019
dc.identifier.citationNiemeijer, A., Lund, H., Stafne, S. N., Ipsen, T., Goldschmidt, C. L., Jørgensen, C. T. & Juhl, C. B. (2019). Adverse events of exercise therapy in randomised controlled trials: a systematic review and meta-analysis. British Journal of Sports Medicine.en_US
dc.identifier.issn0306-3674
dc.identifier.urihttps://hdl.handle.net/11250/2646729
dc.descriptionAuthor's accepted manuscript (postprint).en_US
dc.description.abstractObjective To evaluate the relative risk (RR) of serious and non-serious adverse events in patients treated with exercise therapy compared with those in a non-exercising control group. Design Systematic review and meta-analysis. Data sources Primary studies were identified based on The Cochrane Database of Systematic Reviews investigating the effect of exercise therapy. Eligibility criteria At least two of the authors independently evaluated all identified reviews and primary studies. Randomised controlled trials were included if they compared any exercise therapy intervention with a non-exercising control. Two authors independently extracted data. The RR of serious and non-serious adverse events was estimated separately. Results 180 Cochrane reviews were included and from these, 773 primary studies were identified. Of these, 378 studies (n=38 368 participants) reported serious adverse events and 375 studies (n=38 517 participants) reported non-serious adverse events. We found no increase in risk of serious adverse events (RR=0.96 (95%CI 0.90 to 1.02, I2: 0.0%) due to exercise therapy. There was, however, an increase in non-serious adverse events (RR=1.19 (95%CI 1.09 to 1.30, I2: 0.0%). The number needed to treat for an additional harmful outcome for non-serious adverse events was 6 [95%CI 4 to 11). Conclusion Participating in an exercise intervention increased the relative risk of non-serious adverse events, but not of serious adverse events. Exercise therapy may therefore be recommended as a relatively safe intervention.en_US
dc.language.isoengen_US
dc.publisherBMJ Publishing Groupen_US
dc.titleAdverse events of exercise therapy in randomised controlled trials: A systematic review and meta-analysisen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionacceptedVersionen_US
dc.rights.holder© Author(s) (or their employer(s)) 2019.en_US
dc.source.journalBritish Journal of Sports Medicineen_US
dc.identifier.doi10.1136/bjsports-2018-100461
dc.identifier.cristin1739498
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel